Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

161.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 163.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.69m
  • Volume: 10,898
  • Market Cap: £172.31m
  • RiskGrade: 374

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
8.81% above the market average8.81% above the market average8.81% above the market average8.81% above the market average8.81% above the market average
5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average5.26% above the sector average
1yr Revenue Growth
2.85% below the market average2.85% below the market average2.85% below the market average2.85% below the market average2.85% below the market average
11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average11.76% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
58.26% below the market average58.26% below the market average58.26% below the market average58.26% below the market average58.26% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
1yr DPS Growth
30.71% below the market average30.71% below the market average30.71% below the market average30.71% below the market average30.71% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
40.13% below the market average40.13% below the market average40.13% below the market average40.13% below the market average40.13% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Book Ratio
41.08% below the market average41.08% below the market average41.08% below the market average41.08% below the market average41.08% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
17.07% below the market average17.07% below the market average17.07% below the market average17.07% below the market average17.07% below the market average
10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average10.00% above the sector average
Price Chg 3m
68.21% above the market average68.21% above the market average68.21% above the market average68.21% above the market average68.21% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
9.86% below the market average9.86% below the market average9.86% below the market average9.86% below the market average9.86% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Momentum 20
28.11% below the market average28.11% below the market average28.11% below the market average28.11% below the market average28.11% below the market average
17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average17.95% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
17.66% below the market average17.66% below the market average17.66% below the market average17.66% below the market average17.66% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
ROCE
58.08% above the market average58.08% above the market average58.08% above the market average58.08% above the market average58.08% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
26.22% above the market average26.22% above the market average26.22% above the market average26.22% above the market average26.22% above the market average
58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average58.97% above the sector average
Forecast EPS
26.67% below the market average26.67% below the market average26.67% below the market average26.67% below the market average26.67% below the market average
Sector averageSector averageSector averageSector averageSector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average41.68% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Operating Profit Loss
22.18% above the market average22.18% above the market average22.18% above the market average22.18% above the market average22.18% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.81% above the market average25.81% above the market average25.81% above the market average25.81% above the market average25.81% above the market average
48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average
Cash
1.09% below the market average1.09% below the market average1.09% below the market average1.09% below the market average1.09% below the market average
10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral
90.50% above the market average90.50% above the market average90.50% above the market average90.50% above the market average90.50% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 161.50p
Change Today 0.50p
% Change 0.31 %
52 Week High 163.50
52 Week Low 101.00
Volume 10,898
Shares Issued 106.69m
Market Cap £172.31m
RiskGrade 374

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.72% below the market average86.72% below the market average86.72% below the market average86.72% below the market average86.72% below the market average
10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average10.53% above the sector average
Price Trend
83.59% above the market average83.59% above the market average83.59% above the market average83.59% above the market average83.59% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income
77.03% below the market average77.03% below the market average77.03% below the market average77.03% below the market average77.03% below the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
30.66% below the market average30.66% below the market average30.66% below the market average30.66% below the market average30.66% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  2nd Interim Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 1.00p 1.15p

Trades for 04-Aug-2020

Time Volume / Share Price
14:23 3,616 @ 161.00p
13:56 311 @ 161.00p
13:31 607 @ 161.00p
13:20 4,200 @ 161.00p
11:54 300 @ 161.00p

Cello Health Key Personnel

CEO Mark Scott

Top of Page